John E. Nestler
Virginia Commonwealth University
Medical College of Virginia
Richmond
VA 23298-0111
USA
Name/email consistency: high
- Is metformin or clomiphene citrate more effective for ovulation induction in polycystic ovary syndrome?. Nestler, J.E. Nature Clinical Practice. Endocrinology & Metabolism (2006)
- Should insulin-sensitizing drugs be used in the treatment of polycystic ovary syndrome?. Cheang, K.I., Nestler, J.E. Reprod. Biomed. Online (2004)
- Strategies for the use of insulin-sensitizing drugs to treat infertility in women with polycystic ovary syndrome. Nestler, J.E., Stovall, D., Akhter, N., Iuorno, M.J., Jakubowicz, D.J. Fertil. Steril. (2002)
- Should patients with polycystic ovarian syndrome be treated with metformin?: an enthusiastic endorsement. Nestler, J.E. Hum. Reprod. (2002)
- Obesity, insulin, sex steroids and ovulation. Nestler, J.E. Int. J. Obes. Relat. Metab. Disord. (2000)
- Role of inositolphosphoglycan mediators of insulin action in the polycystic ovary syndrome. Nestler, J.E., Jakubowicz, D.J., Iuorno, M.J. J. Pediatr. Endocrinol. Metab. (2000)
- Ovulatory and metabolic effects of D-chiro-inositol in the polycystic ovary syndrome. Nestler, J.E., Jakubowicz, D.J., Reamer, P., Gunn, R.D., Allan, G. N. Engl. J. Med. (1999)
- Inositolphosphoglycans (IPGs) as mediators of insulin's steroidogenic actions. Nestler, J.E. J. Basic. Clin. Physiol. Pharmacol (1998)
- Insulin stimulates testosterone biosynthesis by human thecal cells from women with polycystic ovary syndrome by activating its own receptor and using inositolglycan mediators as the signal transduction system. Nestler, J.E., Jakubowicz, D.J., de Vargas, A.F., Brik, C., Quintero, N., Medina, F. J. Clin. Endocrinol. Metab. (1998)